Girish C. Shukla

发表

Housekeeping Gene Selection Advisory: Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and β-Actin Are Targets of miR-644a

G. Shukla, Jagjit Singh, Jagjit Singh, 2012, PloS one.

MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways.

M. Campbell, Xiaoqi Liu, C. M. Weyman, 2019, Cancer research.

A Boost for the Emerging Field of RNA Nanotechnology

J. Toulmé, S. Tenenbaum, J. Rossi, 2011, ACS nano.

Differential Expression of Non-Coding RNAs in Stem Cell Development and Therapeutics of Bone Disorders

Satya N. Mishra, N. Gurusamy, S. Vijayaraghavalu, 2023, Cells.

Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression

John T. Wei, S. Dhanasekaran, A. Chinnaiyan, 2018, Nature Genetics.

Targeting of Androgen Receptor Expression by Andro-miRs as Novel Adjunctive Therapeutics in Prostate Cancer

C. M. Weyman, G. Shukla, Girish C. Shukla, 2013, Journal of cancer therapy.

MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.

S. Barik, G. Shukla, Jagjit Singh, 2011, Molecular and cellular pharmacology.

Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancer

Sanjay Gupta, G. Shukla, Girish C. Shukla, 2019, PloS one.

Mutations of RNA splicing factors in hematological malignancies.

G. Shukla, Jagjit Singh, Girish C Shukla, 2017, Cancer letters.

Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells

G. Shukla, Girish C. Shukla, K. Sikand, 2009, Cancer Cell International.

miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies

A. Ting, A. Almasan, G. Shukla, 2015, Molecular Cancer.

The androgen receptor messenger RNA: what do we know?

C. M. Weyman, G. Shukla, Girish C. Shukla, 2022, RNA biology.

Androgen receptor‐related diseases: what do we know?

S. Gupta, G. Shukla, E. Shankar, 2016, Andrology.

Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy

S. Vijayaraghavalu, G. Shukla, Girish C. Shukla, 2022, Cancers.

MicroRNAs in prostate cancer: Functional role as biomarkers.

Xiaoqi Liu, Sanjay Gupta, G. Shukla, 2017, Cancer letters.

U6atac snRNA stem-loop interacts with U12 p65 RNA binding protein and is functionally interchangeable with the U12 apical stem-loop III

A. Komar, C. Will, G. Shukla, 2016, Scientific Reports.

Deep sequencing of small RNA libraries from human prostate epithelial and stromal cells reveal distinct pattern of microRNAs primarily predicted to target growth factors.

Guru Jagadeeswaran, Sanjay Gupta, G. Shukla, 2016, Cancer letters.

MicroRNAs and Androgen Receptor 3' Untranslated Region: A Missing Link in Castration-resistant Prostate Cancer?

S. Barik, G. Shukla, Girish C. Shukla, 2011, Molecular and cellular pharmacology.

Molecular characterization of a novel androgen receptor transgene responsive to MicroRNA mediated post‐transcriptional control exerted via 3′‐untranslated region

G. Shukla, Girish C. Shukla, J. S. Ebron, 2016, The Prostate.

MicroRNA Targets of Human Androgen Receptor

G. Shukla, Girish C. Shukla, 2013 .

miR 488* inhibits androgen receptor expression in prostate carcinoma cells

Rajesh Singh, G. Shukla, Girish C. Shukla, 2011, International journal of cancer.

miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies

A. Ting, A. Almasan, B. Hill, 2015, Molecular Cancer.

A comprehensive review of web-based non-coding RNA resources for cancer research.

G. Shukla, Yun Zheng, Li Liu, 2017, Cancer letters.

Racial disparities: disruptive genes in prostate carcinogenesis.

G. Shukla, Savita Singh, Girish C. Shukla, 2017, Frontiers in bioscience.

Functionally important structural elements of U12 snRNA

G. Shukla, Girish C. Shukla, K. Sikand, 2011, Nucleic acids research.

MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer

Sanjay Gupta, G. Shukla, Savita Singh, 2015, Current Pharmacology Reports.

The muscle regulatory transcription factor MyoD participates with p53 to directly increase the expression of the pro-apoptotic Bcl2 family member PUMA

T. Harford, C. M. Weyman, G. Shukla, 2017, Apoptosis.

Aging and calorie restriction regulate the expression of miR-125a-5p and its target genes Stat3, Casp2 and Stard13

R. Kondratov, Sonal A Patel, Nikkhil Velingkaar, 2017, Aging.

A narrative review on the basic and clinical aspects of the novel SARS-CoV-2, the etiologic agent of COVID-19

M. Tyagi, G. Shukla, Girish C. Shukla, 2020, Annals of translational medicine.

Molecular characterization of a novel androgen receptor transgene responsive to MicroRNA mediated post‐transcriptional control exerted via 3′‐untranslated region

Girish C. Shukla, J. S. Ebron, 2016, The Prostate.

Regulation of cholesterol biosynthesis and lipid metabolism: A microRNA management perspective

C. M. Weyman, G. Shukla, Girish C. Shukla, 2021, Steroids.

Small-Molecule HSP27 Inhibitor Abolishes Androgen Receptors in Glioblastoma.

W. Geldenhuys, G. Shukla, J. Lathia, 2021, Journal of medicinal chemistry.

Basal Signalling Through Death Receptor 5 and Caspase 3 Activates p38 Kinase to Regulate Serum Response Factor (SRF)-Mediated MyoD Transcription

C. M. Weyman, G. Shukla, Girish C. Shukla, 2020, Journal of molecular signaling.

Deep sequencing of small RNA libraries from human prostate epithelial and stromal cells reveal distinct pattern of microRNAs primarily predicted to target growth factors.

Guru Jagadeeswaran, Sanjay Gupta, Yun Zheng, 2016, Cancer letters.